Romanel, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 5.848
EU - Europa 1.808
AS - Asia 1.779
SA - Sud America 423
AF - Africa 36
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.902
Nazione #
US - Stati Uniti d'America 5.776
SG - Singapore 905
CN - Cina 402
RU - Federazione Russa 385
IT - Italia 367
BR - Brasile 351
DE - Germania 277
VN - Vietnam 193
FI - Finlandia 179
GB - Regno Unito 111
SE - Svezia 111
UA - Ucraina 91
LV - Lettonia 89
ID - Indonesia 60
HK - Hong Kong 52
CA - Canada 45
AR - Argentina 36
IN - India 34
BG - Bulgaria 30
JP - Giappone 28
NL - Olanda 26
AT - Austria 23
JO - Giordania 23
PL - Polonia 22
FR - Francia 20
ES - Italia 19
CZ - Repubblica Ceca 15
MX - Messico 15
ZA - Sudafrica 14
IQ - Iraq 13
BD - Bangladesh 11
EC - Ecuador 11
IE - Irlanda 9
UZ - Uzbekistan 9
CO - Colombia 8
AE - Emirati Arabi Uniti 7
LT - Lituania 7
CL - Cile 6
KR - Corea 6
MA - Marocco 6
PK - Pakistan 6
PY - Paraguay 6
TR - Turchia 6
DZ - Algeria 5
NO - Norvegia 5
CH - Svizzera 4
LB - Libano 4
CR - Costa Rica 3
KE - Kenya 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
BE - Belgio 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TJ - Tagikistan 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MC - Monaco 1
MD - Moldavia 1
ME - Montenegro 1
MG - Madagascar 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 9.902
Città #
Fairfield 734
Ashburn 696
Singapore 576
Chandler 530
Woodbridge 333
Seattle 299
Dallas 255
Houston 250
Cambridge 228
Wilmington 220
Santa Clara 189
Jacksonville 184
Columbus 158
Munich 158
Moscow 152
San Mateo 148
Ann Arbor 142
Trento 114
Princeton 111
Helsinki 107
New York 102
Los Angeles 89
Riga 89
Beijing 72
Boardman 54
Hong Kong 52
Ho Chi Minh City 50
Jakarta 50
Como 49
Buffalo 45
Dong Ket 40
San Diego 36
London 34
São Paulo 34
Dearborn 33
Chicago 32
Hefei 31
Hanoi 30
Sofia 30
The Dalles 29
Council Bluffs 25
Bremen 24
Tokyo 24
Redondo Beach 23
Salt Lake City 19
Nuremberg 18
Warsaw 18
Rome 17
San Paolo di Civitate 17
Tolentino 17
Turku 17
Montreal 15
Guangzhou 13
Lappeenranta 13
Lawrence 13
Shanghai 13
Toronto 13
Vienna 13
Frankfurt am Main 12
Phoenix 12
Rio de Janeiro 12
Amsterdam 11
Brno 11
Denver 11
Boston 10
Brooklyn 10
Johannesburg 10
Orem 10
Andover 9
Falkenstein 9
Norwalk 9
Salvador 9
Stockholm 9
Verona 9
Washington 9
Altamura 8
Belo Horizonte 8
Milan 8
Pune 8
Riva Del Garda 8
Tampa 8
Atlanta 7
Baghdad 7
Bend 7
Biên Hòa 7
Bonndorf 7
Castello Molina di Fiemme 7
Changsha 7
Da Nang 7
Falls Church 7
Jyväskylä 7
Manchester 7
San Francisco 7
Tashkent 7
Curitiba 6
Fremont 6
Lavis 6
Miami 6
Ottawa 6
Padova 6
Totale 7.224
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 320
Inherited determinants of early recurrent somatic mutations in prostate cancer 307
A highly specific SpCas9 variant is identified by in vivo screening in yeast 261
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 236
ASEQ: Fast allele-specific studies from next-generation sequencing data 223
EthSEQ: ethnicity annotation from whole exome sequencing data 208
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 205
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma 186
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 182
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 176
Ancestry-specific predisposing germline variants in cancer 169
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 154
Estimating the divisibility of complex biological networks by sparseness indices 149
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 149
Exploring functionally annotated transcriptional consensus regulatory elements with CONREL 149
In-silico identification and functional validation of allele-dependent AR enhancers 145
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 144
The Beta Workbench: a computational tool to study the dynamics of biological systems 143
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 142
Modelling self-assembly in BlenX 141
Exploiting non-Markovian Bio-Processes 139
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 138
Transcriptional regulation is a major controller of cell cycle transition dynamics 134
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 131
BlenX Static and Dynamic Semantics 131
Programming Biology in BlenX 130
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 130
Plasma AR and abiraterone-resistant prostate cancer 129
Analytical protocol to identify local ancestry-associated molecular features in cancer 128
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer 127
One-shot analysis of translated mammalian lncrnas with aharibo 127
Evolving BlenX programs to simulate the evolution of biological networks 126
Modelling and simulation of biological processes in BlenX 124
Punctuated evolution of prostate cancer genomes. 123
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 122
Modeling Static Biological Compartments with Beta-binders 121
Tumor clone dynamics in lethal prostate cancer 120
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care 117
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 116
Exome sequencing of African-American prostate cancer reveals loss-of-function ERF mutations 112
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence 112
Effective Index: A Formal Measure of Drug Effects 110
A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness 109
Unraveling the clonal hierarchy of somatic genomic aberrations 108
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 107
On the Decidability and Complexity of the Structural Congruence for Beta-binders 106
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes 105
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 103
Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations 102
Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster 102
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer 100
On the Computational Power of BlenX 99
Polympact: Exploring functional relations among common human genetic variants 99
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 97
Simple methods for peak and valley detection in time series microrray data 96
Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer 96
Inherited variant in NFκB‐1 promoter is associated with increased risk of IBD in an Algerian population and modulates SOX9 binding 95
Germline determinants of aberrant signaling pathways in cancer 94
BetaWB: modelling and simulating biological processes 93
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice 92
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response 90
Allele-specific expression analysis in cancer using next-generation sequencing data 90
On the impact of discreteness and abstractions on modelling noise in gene regulatory networks 89
The Decidability of the Structural Congruence for Beta-binders 88
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 88
SpikeFlow: automated and flexible analysis of ChIP-Seq data with spike-in control 87
The BlenX Language: A Tutorial 87
Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers 80
TRPM8 levels determine tumor vulnerability to channel agonists. 78
Towards a process calculi approach to study the evolution of biological networks 78
Self-assembly processes with cooperativity 75
Analysis of germline-driven ancestry-associated gene expression in cancers 70
The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes 66
Simple methods for peak and valley detection in time series microarray data 64
A Formal and Integrated Framework to Simulate Evolution of Biological Pathways 64
Analysis of Genetic Ancestry from NGS Data Using EthSEQ 61
Synggen: fast and data-driven generation of synthetic heterogeneous NGS cancer data 58
Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer 58
The BlenX Language: A Tutorial 55
Dynamic Biological Modelling: a language-based approach 53
Effective Index: A Formal Measure of Drug Effects 52
The Beta Workbench 46
Beta-binders with Static Compartments 44
On the Decidability and Complexity of the Structural Congruence for Beta-binders 40
On the Computational Power of BlenX 38
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 36
Simulation of non-Markovian Processes in BlenX 35
Integrative Computational Analysis of Common EXO5 Haplotypes: Impact on Protein Dynamics, Genome Stability, and Cancer Progression 34
Totale 10.143
Categoria #
all - tutte 43.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.369
Totale 45.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021719 0 0 0 0 0 105 87 88 71 105 137 126
2021/2022914 77 110 10 42 31 34 17 178 60 90 92 173
2022/20231.072 157 155 14 186 87 148 10 86 122 15 53 39
2023/2024560 25 34 34 11 58 154 33 56 23 38 10 84
2024/20252.326 26 20 176 419 104 272 144 119 235 410 162 239
2025/20262.413 383 138 597 665 464 166 0 0 0 0 0 0
Totale 10.143